ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 123111 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 123111; 2) Community: the network communities that were significantly associated with the response to NSC 123111; 3) Molecule: the relationships between components within communities and NSC 123111; 4) MDR: the compounds that were significantly associated with the NSC 123111.

NSC Compound Enrichment Correlation
NSC 133072 Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) 0.0273093708703115 0.2738945
NSC 281383 Null 0.0273093708703115 0.35834055
NSC 610458 Camptothecin Derivative 0.0273093708703115 0.62439416
NSC 610459 Camptothecin Derivative 0.0273093708703115 0.63340866
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0273093708703115 0.263631
NSC 638441 Null 0.0273093708703115 0.42567721
NSC 642954 Null 0.0273093708703115 0.34199147
NSC 659162 1H-Benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9CI) 0.0273093708703115 0.23227797
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0273093708703115 0.376715
NSC 662123 Null 0.0273093708703115 -0.071522087
Total:79  Current:51    [First] [Prev] [Next] [Last]